# LEVAQUIN
> **NDA021721** · New Drug Application · Sponsor: JANSSEN PHARMS · Approved 2004-10-21
## Drug
- **FDA Application Number:** NDA021721
- **Application type:** New Drug Application
- **Brand name:** LEVAQUIN
- **Generic name:** Levofloxacin
- **Active ingredients:** LEVOFLOXACIN
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** JANSSEN PHARMS
- **First approval:** 2004-10-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021721)
---
*AI Analytics · CC0 1.0*